SkyAI, Inc. (Nasdaq: SKYA), formerly Sharps Technology, Inc., files with the SEC as a Nevada corporation with its principal executive office in Melville, New York, and a fiscal year that ends December 31. The annual report on Form 10-K and quarterly reports on Form 10-Q cover operating and financial results, with segment reporting that separates the digital asset treasury from the legacy medical device business, along with capital structure, material agreements, related-party consulting and advisory arrangements, and governance matters.
Current reports on Form 8-K record the change of name and ticker under Item 5.03, along with amended and restated bylaws that added advance notice requirements for stockholder proposals and director nominations and a Nevada exclusive forum provision. Other 8-Ks cover an updated code of business conduct and ethics under Item 5.05, annual meeting vote results under Item 5.07, officer appointments and employment agreements, a lock-up agreement with a strategic advisor, and, under Item 8.01, the special committee’s and the board’s conclusion on Forward Industries’ initial all-stock proposal.
The DEF 14A proxy statement covers the annual meeting, including director elections, ratification of the independent registered public accounting firm and an equity incentive plan, and describes the company’s repositioning from its medical device business to a digital asset treasury strategy. Registration statements on Form S-3 cover securities offerings. Insiders report their holdings and trades on Forms 3 and 4, and shareholders with stakes above five percent report them on Schedule 13D and Schedule 13G.
Saba Capital Management, L.P., a more than 10% owner of Sharps Technology Inc. (STSS), reported selling common stock in two transactions. On January 15, 2026, it sold 25,000 shares at $2.30 per share. On January 16, 2026, it sold an additional 12,182 shares at $2.37 per share.
After these sales, Saba Capital Management, L.P. beneficially owned 1,511,988 shares of Sharps Technology common stock, held indirectly. The filing notes that, as a result of the January 16, 2026 disposition, the reporting person now owns less than 10% of the issuer’s outstanding shares.
Sharps Technology, Inc. reported that on January 15, 2026 it entered into a 90-day lock-up agreement with Sol Markets, described as its strategic advisor. Under this agreement, Sol Markets agreed that for ninety days it will not offer, sell, pledge or otherwise dispose of any Sharps common stock or any securities that can be converted, exchanged or exercised into Sharps common stock that it beneficially owns or later acquires.
The company also noted that on January 16, 2026 it issued a press release announcing, among other items, its entry into this lock-up agreement. The lock-up terms are intended to temporarily restrict potential share sales by this advisor, and the full agreement and press release are included as exhibits to the report.
Sharps Technology, Inc. reported several corporate governance updates approved by its board of directors on January 15, 2026. The company adopted amended and restated bylaws that, among other changes, require stockholder actions to be taken at duly called meetings, introduce advance notice requirements for stockholder proposals and director nominations, and establish Nevada as the exclusive forum for certain legal actions.
The board also adopted an amended and restated Code of Business Conduct and Ethics, updating it for current governance, ethics, and compliance practices and streamlining overlapping company policies. In addition, the board approved charters for the Audit Committee, Compensation Committee, and Nominating Committee, formally setting out how these key board committees will operate.
Saba Capital Management and affiliates have filed an amended Schedule 13G reporting a significant passive stake in Sharps Technology, Inc. The filing shows that Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (together, the reporting persons) beneficially own 3,195,097 shares of Sharps Technology common stock and warrants, representing 10.46% of the class.
The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025, plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons. All 3,195,097 shares are reported with shared voting and shared dispositive power, and none with sole power. The funds and accounts advised by Saba Capital have the right to receive dividends and sale proceeds, and the reporting persons certify the securities are not held to change or influence control of Sharps Technology.
Saba Capital Management and affiliates have reported a significant stake in Sharps Technology, Inc. In this amended Schedule 13G, Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein disclose beneficial ownership of 1,741,214 shares and warrants of Sharps Technology common stock, representing 5.93% of the class as of the event date of 12/31/2025.
The ownership percentage is based on 28,995,402 shares outstanding as of December 15, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons. All voting and dispositive power over these securities is reported as shared, with no sole voting or dispositive power. The filing states that the securities were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology, characterizing this as a passive investment position held on behalf of funds and accounts advised by Saba Capital.
Saba Capital Management and related parties have disclosed a new passive stake in Sharps Technology, Inc. The group, including Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, reports beneficial ownership of 1,583,749 shares and warrants of Sharps Technology common stock, equal to 5.53% of the class.
The ownership percentage is based on 28,226,153 shares outstanding as of October 17, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons. The securities are held for the benefit of funds and accounts advised by Saba Capital. The filers certify that the holdings were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology.
Sharps Technology Inc. large shareholder Saba Capital Management, L.P. reported two sales of the company’s common stock. On January 13, 2026, Saba Capital sold 29,777 shares at a price of $2.19 per share. On January 14, 2026, it sold another 77,688 shares at $2.25 per share. After these indirect transactions, Saba Capital reported beneficial ownership of 1,626,858 shares following the first sale and 1,549,170 shares following the second sale.
Saba Capital Management, L.P. has filed an initial ownership report as a 10% owner of Sharps Technology Inc. (STSS) as of 01/09/2026. The filing shows indirect beneficial ownership of 1,656,635 shares of common stock.
Saba Capital also indirectly holds cash stapled warrants exercisable into 1,538,462 shares of common stock at an exercise price of $9.75, expiring on 11/04/2028, and pre-funded warrants for 388,462 shares of common stock at $6.50 per share, noted as expiring when exercised in full.
Sharps Technology (STSS) filed its Q3 2025 10‑Q, highlighting a major shift to a digital‑asset treasury anchored in Solana (SOL). As of September 30, total assets were $443.96M, including SOL at fair value of $404.20M and USDC of $14.70M. Cash was $10.52M. Management states current liquidity is sufficient for the next twelve months and no longer raises substantial doubt about going concern.
Operations reflected the pivot: product revenue was $83,622, and staking revenue was $2,205,423. The quarter included significant operating costs, including selling, general and administrative expenses of $110.72M and a $7.50M impairment of fixed assets tied to the exit from manufacturing, resulting in a net loss of $105.33M. A 10% change in SOL prices would have impacted income by about $40.4M for the period, underscoring market sensitivity.
Financing activity was robust, with $210.73M of net cash provided year‑to‑date. The company received $144.04M of digital assets and $86.10M of USDC from common stock issuances. Shares outstanding were 27,626,498 at quarter‑end and 28,226,153 as of November 14, 2025. Sharps now reports two segments: Medical Device Packaging Products and Digital Assets.
Sharps Technology, Inc. (Nasdaq: STSS) filed a resale registration statement covering shares issued in a private placement and shares underlying multiple warrant classes. This prospectus permits Selling Stockholders to offer and resell: 24,338,649 common shares, plus warrant shares including 13,884,617 from cash pre‑funded warrants (exercise price $0.0001), 38,223,266 from cash stapled warrants (exercise price $9.75), 24,836,560 from cryptocurrency pre‑funded warrants (exercise price $0.0001), 24,836,560 from cryptocurrency stapled warrants (exercise price $9.75), and 6,321,367 from strategic advisor warrants (exercise price $0.0001).
The company is not selling shares and will not receive proceeds from Selling Stockholder sales. It could receive up to $614,837,807.75 in gross proceeds if all warrants are exercised. Shares outstanding were 28,226,153 as of October 17, 2025. The company highlights extensive risk factors tied to its SOL-focused digital asset treasury strategy, staking operations, market volatility, custody, DeFi usage, and evolving regulation.